Immuron Limited - Warrants (12/05/2022) Profit Margin

Immuron Limited - Warrants (12/05/2022) (IMRNW) currently reports a profit margin of -59.97% as of June 2026. That compares with -105.94% in the prior-year period — up 43.4% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Immuron Limited - Warrants (12/05/2022)'s profit margin history and peer comparisons.

Immuron Limited - Warrants (12/05/2022)'s profit margin increased from -105.94% to -59.97% — a 43.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immuron Limited - Warrants (12/05/2022)'s profit margin of -59.97% is lower than the Healthcare sector average of 13.76%. That is roughly 535.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Immuron Limited - Warrants (12/05/2022)'s current -59.97% should be judged against Healthcare norms (sector average: 13.76%) and against IMRNW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -59.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Immuron Limited - Warrants (12/05/2022), and consider following IMRNW for alerts when major investors trade the stock.